Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294203047> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4294203047 endingPage "S719" @default.
- W4294203047 startingPage "S719" @default.
- W4294203047 abstract "Introduction Clozapine is commonly associated with hematological side effects. However, little research is available on the impact of adding other psychotropic medication on inducing blood dyscrasias. Objectives The aim of the study was to explore the impact of associating psychotropic medication to clozapine in producing hematological abnormalities. Methods Our study was a longitudinal, retrospective chart review of adult psychiatric patients receiving clozapine treatment at our clozapine consultation between January 2000 and September 2020. Results Our sample consisted of 15 women (23.5%) and 49 men (76.5%), mean age was 41.34 ±9.32 years. Polypharmacy was found in 70.3% of the cases. Association of clozapine to other psychotropic agents was found in 67.2% of the cases. Most prescribed add-on medication was valproic acid in 27 cases, benzodiazepines in 21 cases, promethazine and hydroxyzine in 16 cases, lithium in 8 cases and haloperidol in 6 cases. We found blood dyscrasias in 21 patients (32.8%). Hematological abnormalities were as follow: 2 cases of agranulocytosis, 8 cases of neutropenia, 13 cases of thrombocytopenia, 5 cases of leukocytosis, 5 cases of eosinophilia and 3 cases of anemia. In our sample we did not find a significant association between psychotropic polypharmacy and blood dyscrasias. Conclusions Many psychiatric patients on clozapine require polypharmacy to better stabilize their condition. Such co prescriptions may carry the risk of inducing more side effects especially blood dyscrasias. In our study, we did not find a significant association between psychotropic medication added to clozapine and hematological abnormalities. But further research is warranted to better explore this association. Disclosure No significant relationships." @default.
- W4294203047 created "2022-09-02" @default.
- W4294203047 creator A5026123092 @default.
- W4294203047 creator A5049449527 @default.
- W4294203047 creator A5077985584 @default.
- W4294203047 creator A5088321852 @default.
- W4294203047 date "2022-06-01" @default.
- W4294203047 modified "2023-09-30" @default.
- W4294203047 title "Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients" @default.
- W4294203047 doi "https://doi.org/10.1192/j.eurpsy.2022.1855" @default.
- W4294203047 hasPublicationYear "2022" @default.
- W4294203047 type Work @default.
- W4294203047 citedByCount "0" @default.
- W4294203047 crossrefType "journal-article" @default.
- W4294203047 hasAuthorship W4294203047A5026123092 @default.
- W4294203047 hasAuthorship W4294203047A5049449527 @default.
- W4294203047 hasAuthorship W4294203047A5077985584 @default.
- W4294203047 hasAuthorship W4294203047A5088321852 @default.
- W4294203047 hasBestOaLocation W42942030471 @default.
- W4294203047 hasConcept C113775271 @default.
- W4294203047 hasConcept C118552586 @default.
- W4294203047 hasConcept C126322002 @default.
- W4294203047 hasConcept C187212893 @default.
- W4294203047 hasConcept C2776364478 @default.
- W4294203047 hasConcept C2776396001 @default.
- W4294203047 hasConcept C2776412080 @default.
- W4294203047 hasConcept C2776694085 @default.
- W4294203047 hasConcept C2777063308 @default.
- W4294203047 hasConcept C2778923028 @default.
- W4294203047 hasConcept C2780035454 @default.
- W4294203047 hasConcept C2780864610 @default.
- W4294203047 hasConcept C2993714069 @default.
- W4294203047 hasConcept C36434225 @default.
- W4294203047 hasConcept C71924100 @default.
- W4294203047 hasConceptScore W4294203047C113775271 @default.
- W4294203047 hasConceptScore W4294203047C118552586 @default.
- W4294203047 hasConceptScore W4294203047C126322002 @default.
- W4294203047 hasConceptScore W4294203047C187212893 @default.
- W4294203047 hasConceptScore W4294203047C2776364478 @default.
- W4294203047 hasConceptScore W4294203047C2776396001 @default.
- W4294203047 hasConceptScore W4294203047C2776412080 @default.
- W4294203047 hasConceptScore W4294203047C2776694085 @default.
- W4294203047 hasConceptScore W4294203047C2777063308 @default.
- W4294203047 hasConceptScore W4294203047C2778923028 @default.
- W4294203047 hasConceptScore W4294203047C2780035454 @default.
- W4294203047 hasConceptScore W4294203047C2780864610 @default.
- W4294203047 hasConceptScore W4294203047C2993714069 @default.
- W4294203047 hasConceptScore W4294203047C36434225 @default.
- W4294203047 hasConceptScore W4294203047C71924100 @default.
- W4294203047 hasIssue "S1" @default.
- W4294203047 hasLocation W42942030471 @default.
- W4294203047 hasLocation W42942030472 @default.
- W4294203047 hasOpenAccess W4294203047 @default.
- W4294203047 hasPrimaryLocation W42942030471 @default.
- W4294203047 hasRelatedWork W1987240985 @default.
- W4294203047 hasRelatedWork W2081866209 @default.
- W4294203047 hasRelatedWork W2090773853 @default.
- W4294203047 hasRelatedWork W2143333002 @default.
- W4294203047 hasRelatedWork W2152307767 @default.
- W4294203047 hasRelatedWork W2354396718 @default.
- W4294203047 hasRelatedWork W2395671838 @default.
- W4294203047 hasRelatedWork W2556479207 @default.
- W4294203047 hasRelatedWork W4294203047 @default.
- W4294203047 hasRelatedWork W4313367373 @default.
- W4294203047 hasVolume "65" @default.
- W4294203047 isParatext "false" @default.
- W4294203047 isRetracted "false" @default.
- W4294203047 workType "article" @default.